FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Erik Thompson

Research Profile

Disorders

Anatomy

Living Beings

Chemicals & Drugs

Physiology

Procedures

Tissue Engineering

Co-author Network

Publications

TOP 3
N P A Devika Gunasinghe; Erik W Thompson; Alan Wells; Honor J Hugo
Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer.
G L Chew; Izhak Haviv; M A Henderson; P Hill; John L Hopper; D Huang; C Huo; S J Lin; W A Morrison; Melissa C Southey; Tony Blick; Ian G Campbell; Jennifer N Cawson; Erik W Thompson
High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers.
Ardian Latifi; Rodney B Luwor; Simon Nazaretian; Jan Pyman; Michael A Quinn; Kaye L Stenvers; Erik W Thompson; Hongjian Zhu; Maree Bilandzic; Jock K Findlay; Nuzhat Ahmed
Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Erik Thompson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: N P A Devika Gunasinghe; Erik W Thompson; Alan Wells; Honor J Hugo
Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer.
Cancer metastasis reviews 2012;31(3-4):469-78.
2012: G L Chew; Izhak Haviv; M A Henderson; P Hill; John L Hopper; D Huang; C Huo; S J Lin; W A Morrison; Melissa C Southey; Tony Blick; Ian G Campbell; Jennifer N Cawson; Erik W Thompson
High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers.
Breast cancer research and treatment 2012;135(1):177-87.
2012: Ardian Latifi; Rodney B Luwor; Simon Nazaretian; Jan Pyman; Michael A Quinn; Kaye L Stenvers; Erik W Thompson; Hongjian Zhu; Maree Bilandzic; Jock K Findlay; Nuzhat Ahmed
Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.
PloS one 2012;7(10):e46858.
2012: Manisha Shah; Mark Waltham; Tony Blick; Andrea Connor; Joel R Hardink; Dexing Huang; Conor C Lynch; Lawrence A Reiter; Erik W Thompson
An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer.
PloS one 2012;7(1):e29615.
2011: Ardian Latifi; Clifford Liongue; Michael A Quinn; Erik W Thompson; Alister C Ward; Natalie Castrechini; Francoise Dobill; Jock K Findlay; Janani Kumar; Khalid Abubaker; Nuzhat Ahmed
Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.
Journal of cellular biochemistry 2011;112(10):2850-64.
2011: Suling J Lin; Melissa C Southey; Ian G Campbell; Jennifer Cawson; Izhak Haviv; Prue Hill; John L Hopper; Mark Jenkins; Erik W Thompson
Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue.
Breast cancer research and treatment 2011;128(2):505-16.
2011: Erik W Thompson; Raymond Runyan; Pierre Savagner; Donald F Newgreen
Out of the desert: the 4th TEMTIA Meeting on new advances in development, fibrosis and cancer.
Cells, tissues, organs 2011;193(1-2):4-7.
2011: Honor J Hugo; Maria I Kokkinos; Tony Blick; M Leigh Ackland; Erik W Thompson; Donald F Newgreen
Defining the E-cadherin repressor interactome in epithelial-mesenchymal transition: the PMC42 model as a case study.
Cells, tissues, organs 2011;193(1-2):23-40.
2010: Filip B Stillaert; Keren M Abberton; Effie Keramidaris; Erik W Thompson; Phillip N Blondeel; Wayne A Morrison
Intrinsics and dynamics of fat grafts: an in vitro study.
Plastic and reconstructive surgery 2010;126(4):1155-62.
2010: Maria I Kokkinos; Padma Murthi; R Wafai; Erik W Thompson; Donald F Newgreen
Cadherins in the human placenta--epithelial-mesenchymal transition (EMT) and placental development.
Placenta 2010;31(9):747-55.
2010: Tony Blick; Honor Hugo; Edwin Widodo; Mark Waltham; Cletus Pinto; Sendurai Mani; Robert A Weinberg; Richard M Neve; Marc E Lenburg; Erik W Thompson
Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.
Journal of mammary gland biology and neoplasia 2010;15(2):235-52.
2010: Arnaud Bonnomet; Anne Brysse; Anthony Tachsidis; Mark Waltham; Erik W Thompson; Myriam Polette; Christine Gilles
Epithelial-to-mesenchymal transitions and circulating tumor cells.
Journal of mammary gland biology and neoplasia 2010;15(2):261-73.
2010: Erik W Thompson; Kristina Warton; Tony Blick; Razan Wafai; Prue Hill; Keith Stanley
Multiplexed tandem polymerase chain reaction identifies strong expression of oestrogen receptor and Her-2 from single, formalin-fixed, paraffin-embedded breast cancer sections.
Pathology 2010;42(2):165-72.
2010: Daniel J Tilkorn; Zerina Lokmic; Christine L Chaffer; Geraldine M Mitchell; Wayne A Morrison; Erik W Thompson
Disparate companions: tissue engineering meets cancer research.
Cells, tissues, organs 2010;192(3):141-57.
2009: Michael W Findlay; Aurora Messina; Erik W Thompson; Wayne A Morrison
Long-term persistence of tissue-engineered adipose flaps in a murine model to 1 year: an update.
Plastic and reconstructive surgery 2009;124(4):1077-84.
2009: Kevin J Cronin; Aurora Messina; Erik W Thompson; Wayne A Morrison; Geoffrey W Stevens; Kenneth R Knight
Retraction. The role of biological extracellular matrix scaffolds in vascularized three-dimensional tissue growth in vivo.
Journal of biomedical materials research. Part B, Applied biomaterials 2009;89(2):575.
2009: Jeremy W Simcock; Anthony J Penington; Wayne A Morrison; Erik W Thompson; Geraldine M Mitchell
Endothelial precursor cells home to a vascularized tissue engineering chamber by application of the angiogenic chemokine CXCL12.
Tissue engineering. Part A 2009;15(3):655-64.
2009: Honor J Hugo; Razan Wafai; Tony Blick; Erik W Thompson; Donald F Newgreen
Staurosporine augments EGF-mediated EMT in PMC42-LA cells through actin depolymerisation, focal contact size reduction and Snail1 induction - a model for cross-modulation.
BMC cancer 2009;9():235.
2008: Zerina Lokmic; James L Thomas; Wayne A Morrison; Erik W Thompson; Geraldine M Mitchell
An endogenously deposited fibrin scaffold determines construct size in the surgically created arteriovenous loop chamber model of tissue engineering.
Journal of vascular surgery 2008;48(4):974-85.
2008: Aditya V Vashi; Effie Keramidaris; Keren Abberton; Wayne A Morrison; Jeremy L Wilson; Andrea J O'Connor; Justin J Cooper-White; Erik W Thompson
Adipose differentiation of bone marrow-derived mesenchymal stem cells using Pluronic F-127 hydrogel in vitro.
Biomaterials 2008;29(5):573-9.
2008: G P L Thomas; Karsten Hemmrich; Keren Abberton; David McCombe; Anthony J Penington; Erik W Thompson; Wayne A Morrison
Zymosan-induced inflammation stimulates neo-adipogenesis.
International journal of obesity (2005) 2008;32(2):239-48.
2008: Erik W Thompson; Elizabeth D Williams
EMT and MET in carcinoma--clinical observations, regulatory pathways and new models.
Clinical & experimental metastasis 2008;25(6):591-2.
2008: Keren Abberton; S K Bortolotto; A A Woods; M Findlay; Wayne A Morrison; Erik W Thompson; Aurora Messina
Myogel, a novel, basement membrane-rich, extracellular matrix derived from skeletal muscle, is highly adipogenic in vivo and in vitro.
Cells, tissues, organs 2008;188(4):347-58.
2007: Karsten Hemmrich; Gregory P L Thomas; Keren Abberton; Erik W Thompson; John A Rophael; Anthony J Penington; Wayne A Morrison
Monocyte chemoattractant protein-1 and nitric oxide promote adipogenesis in a model that mimics obesity.
Obesity (Silver Spring, Md.) 2007;15(12):2951-7.
2007: Christine L Chaffer; Bonnie Dopheide; Pierre Savagner; Erik W Thompson; Elizabeth D Williams
Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.
Differentiation; research in biological diversity 2007;75(9):831-42.
2007: Honor Hugo; M Leigh Ackland; Tony Blick; Mitchell G Lawrence; Judith A Clements; Elizabeth D Williams; Erik W Thompson
Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.
Journal of cellular physiology 2007;213(2):374-83.
2007: Filip Stillaert; Michael Findlay; Jason Palmer; Rejhan Idrizi; Shirley Cheang; Aurora Messina; Keren Abberton; Wayne Morrison; Erik W Thompson
Host rather than graft origin of Matrigel-induced adipose tissue in the murine tissue-engineering chamber.
Tissue engineering 2007;13(9):2291-300.
2007: Kevin J Cronin; Aurora Messina; Erik W Thompson; Wayne A Morrison; Geoffrey W Stevens; Kenneth R Knight
The role of biological extracellular matrix scaffolds in vascularized three-dimensional tissue growth in vivo.
Journal of biomedical materials research. Part B, Applied biomaterials 2007;82(1):122-8.
2007: Ratana Lim; Nuzhat Ahmed; Niels Borregaard; Clyde Riley; Razan Wafai; Erik W Thompson; Michael A Quinn; Gregroy Edward Rice
Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition.
International journal of cancer. Journal international du cancer 2007;120(11):2426-34.
2007: Kulrut Borrirukwanit; Marc A Lafleur; Francesca A Mercuri; Tony Blick; John T Price; Rafael Fridman; Joseph J Pereira; Vijittra Leardkamonkarn; Erik W Thompson
The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells.
Matrix biology : journal of the International Society for Matrix Biology 2007;26(4):291-305.
2007: Juergen H Dolderer; Keren Abberton; Erik W Thompson; John L Slavin; Geoffrey W Stevens; Anthony J Penington; Wayne A Morrison
Spontaneous large volume adipose tissue generation from a vascularized pedicled fat flap inside a chamber space.
Tissue engineering 2007;13(4):673-81.
2007: Zerina Lokmic; Filip Stillaert; Wayne A Morrison; Erik W Thompson; Geraldine M Mitchell
An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(2):511-22.
2007: Maria I Kokkinos; Razan Wafai; Meng Kang Wong; Donald F Newgreen; Erik W Thompson; Mark Waltham
Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo.
Cells, tissues, organs 2007;185(1-3):191-203.
2007: Christine L Chaffer; Erik W Thompson; Elizabeth D Williams
Mesenchymal to epithelial transition in development and disease.
Cells, tissues, organs 2007;185(1-3):7-19.
2007: Stephanie C Lebret; Donald F Newgreen; Erik W Thompson; M Leigh Ackland
Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors.
Breast cancer research : BCR 2007;9(1):R19.
2006: Christine L Chaffer; Janelle P Brennan; John L Slavin; Tony Blick; Erik W Thompson; Elizabeth D Williams
Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
Cancer research 2006;66(23):11271-8.
2006: Aditya V Vashi; Keren Abberton; Gregory P Thomas; Wayne A Morrison; Andrea J O'Connor; Justin J Cooper-White; Erik W Thompson
Adipose tissue engineering based on the controlled release of fibroblast growth factor-2 in a collagen matrix.
Tissue engineering 2006;12(11):3035-43.
2006: Stephanie C Lebret; Donald F Newgreen; Mark Waltham; John T Price; Erik W Thompson; M Leigh Ackland
Myoepithelial molecular markers in human breast carcinoma PMC42-LA cells are induced by extracellular matrix and stromal cells.
In vitro cellular & developmental biology. Animal 2006;42(10):298-307.
2006: DB McCombe; M Kubicki; C Witschi; J Williams; Erik W Thompson
A collagen prolyl 4-hydroxylase inhibitor reduces adhesions after tendon injury.
Clinical orthopaedics and related research 2006;451():251-6.
2006: John L Kelly; Michael W Findlay; Kenneth R Knight; Anthony J Penington; Erik W Thompson; Aurora Messina; Wayne A Morrison
Contact with existing adipose tissue is inductive for adipogenesis in matrigel.
Tissue engineering 2006;12(7):2041-7.
2006: Zerina Lokmic; Ian A Darby; Erik W Thompson; Geraldine M Mitchell
Time course analysis of hypoxia, granulation tissue and blood vessel growth, and remodeling in healing rat cutaneous incisional primary intention wounds.
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2006;14(3):277-88.
2006: Marc A Lafleur; Francesca A Mercuri; Neeracha Ruangpanit; Motoharu Seiki; Hiroshi Sato; Erik W Thompson
Type I collagen abrogates the clathrin-mediated internalization of membrane type 1 matrix metalloproteinase (MT1-MMP) via the MT1-MMP hemopexin domain.
The Journal of biological chemistry 2006;281(10):6826-40.
2006: Tanida Srisuwan; Daniel J Tilkorn; Jeremy L Wilson; Wayne A Morrison; Harold M Messer; Erik W Thompson; Keren Abberton
Molecular aspects of tissue engineering in the dental field.
Periodontology 2000 2006;41():88-108.
2006: Christine L Chaffer; David M Thomas; Erik W Thompson; Elizabeth D Williams
PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma.
BMC cancer 2006;6():53.
2005: Daniel McCulloch; Kenneth Opeskin; Erik W Thompson; Elizabeth D Williams
BM18: A novel androgen-dependent human prostate cancer xenograft model derived from a bone metastasis.
The Prostate 2005;65(1):35-43.
2005: Yasumasa Kato; Mamoru Tsukuda; Yoji Nagashima; Shinri Koshika; Naoki Sakai; Masahiro Yao; Yoshinobu Kubota; Ichiro Aoki; William H Colledge; Jean-Michel Foidart; Ryu-Ichiro Hata; Erik W Thompson
Reduced excision repair cross-complementing 1 expression associates with enhanced papilloma formation and fibroblast transformation after genetic disruption of secreted protein acidic and rich in cysteine.
International journal of oncology 2005;27(3):759-68.
2005: Lishanthi Udabage; Gary R Brownlee; Mark Waltham; Tony Blick; Emma C Walker; Paraskevi Heldin; Susan K Nilsson; Erik W Thompson; Tracey Brown
Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer.
Cancer research 2005;65(14):6139-50.
2005: David Tarin; Erik W Thompson; Donald F Newgreen
The fallacy of epithelial mesenchymal transition in neoplasia.
Cancer research 2005;65(14):5996-6000; discussion 6000-1.
2005: Erik W Thompson; Donald F Newgreen; David Tarin
Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?
Cancer research 2005;65(14):5991-5; discussion 5995.
2005: John T Price; Julian M W Quinn; Natalie Sims; Jessica Vieusseux; Kelly Waldeck; Susan E Docherty; Damian Myers; Akira Nakamura; Mark Waltham; Matthew T Gillespie; Erik W Thompson
The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
Cancer research 2005;65(11):4929-38.
2005: Marc A Lafleur; Angela F Drew; Emma L de Sousa; Tony Blick; Margaret Bills; Emma C Walker; Elizabeth D Williams; Mark Waltham; Erik W Thompson
Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
International journal of cancer. Journal international du cancer 2005;114(4):544-54.
2005: Annet Hammacher; Erik W Thompson; Elizabeth D Williams
Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer.
The international journal of biochemistry & cell biology 2005;37(2):442-50.
2005: Christine L Chaffer; Bonnie Dopheide; Daniel McCulloch; Allan B Lee; Jane M Moseley; Erik W Thompson; Elizabeth D Williams
Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder.
Clinical & experimental metastasis 2005;22(2):115-25.
2004: Angela F Drew; Tony Blick; Marc A Lafleur; E L M Tim; M J Robbie; Gregroy Edward Rice; Michael A Quinn; Erik W Thompson
Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
Gynecologic oncology 2004;95(3):437-48.
2004: Joseph J Pereira; Tim Meyer; Susan E Docherty; Hugh Reid; John Marshall; Erik W Thompson; Jamie Rossjohn; John T Price
Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth.
Cancer research 2004;64(3):977-84.
2004: Angus M Tester; Mark Waltham; Se-Jeong Oh; Seog Nyeon Bae; Margaret M Bills; Emma C Walker; Francis G Kern; William Stetler-Stevenson; Marc Lippman; Erik W Thompson
Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice.
Cancer research 2004;64(2):652-8.
2004: James M Rae; Susan J Ramus; Mark Waltham; Jane E Armes; Ian G Campbell; Robert Clarke; Robert J Barndt; Michael Johnson; Erik W Thompson
Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties.
Clinical & experimental metastasis 2004;21(6):543-52.
2004: Erik W Thompson; Mark Waltham; Susan J Ramus; Anne-Marie Hutchins; Jane E Armes; Ian G Campbell; Elizabeth D Williams; Phillip R Thompson; James M Rae; Michael Johnson; Robert Clarke
LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines.
Clinical & experimental metastasis 2004;21(6):535-41.
2004: Julie A Sharp; Mark Waltham; Elizabeth D Williams; Michael A Henderson; Erik W Thompson
Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice.
Clinical & experimental metastasis 2004;21(1):19-29.
2003: Marc A Lafleur; Angus M Tester; Erik W Thompson
Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism.
FEBS letters 2003;553(3):457-63.
2003: M Leigh Ackland; Donald F Newgreen; Masha Fridman; Mark Waltham; Angela Arvanitis; Joseph Minichiello; John T Price; Erik W Thompson
Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells.
Laboratory investigation; a journal of technical methods and pathology 2003;83(3):435-48.
2002: Nirada Dhanesuan; Julie A Sharp; Tony Blick; John T Price; Erik W Thompson
Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition.
Breast cancer research and treatment 2002;75(1):73-85.
2002: John T Price; Erik W Thompson
Mechanisms of tumour invasion and metastasis: emerging targets for therapy.
Expert opinion on therapeutic targets 2002;6(2):217-33.
2002: Nor Eddine SOUNNI; Laetitia Devy; Amin Hajitou; Francis Frankenne; Carine Munaut; Christine Gilles; Christophe Deroanne; Erik W Thompson; Jean-Michel Foidart; Agnès Noel
MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(6):555-64.
2002: Neeracha Ruangpanit; John T Price; Kenn Holmbeck; Henning Birkedal-Hansen; Volkmar Guenzler; Xinfan Huang; Danny Chan; John F Bateman; Erik W Thompson
MT1-MMP-dependent and -independent regulation of gelatinase A activation in long-term, ascorbate-treated fibroblast cultures: regulation by fibrillar collagen.
Experimental cell research 2002;272(2):109-18.
2002: Angus M Tester; Julie A Sharp; Nirada Dhanesuan; Mark Waltham; Erik W Thompson
Correlation between extent of osteolytic damage and metastatic burden of human breast cancer metastasis in nude mice: real-time PCR quantitation.
Clinical & experimental metastasis 2002;19(5):377-83.
2001: Oliver C S Cassell; Wayne A Morrison; Aurora Messina; Anthony J Penington; Erik W Thompson; Geoffrey W Stevens; Jilska M Perera; H K Kleinman; JV Hurley; R Romeo; Kenneth R Knight
The influence of extracellular matrix on the generation of vascularized, engineered, transplantable tissue.
Annals of the New York Academy of Sciences 2001;944():429-42.
2001: Neeracha Ruangpanit; D Chan; Kenn Holmbeck; Henning Birkedal-Hansen; J Polarek; C Yang; J F Bateman; Erik W Thompson
Gelatinase A (MMP-2) activation by skin fibroblasts: dependence on MT1-MMP expression and fibrillar collagen form.
Matrix biology : journal of the International Society for Matrix Biology 2001;20(3):193-203.
2000: M M Hijazi; Erik W Thompson; C Tang; Peter J Coopman; JA Torri; D Yang; Susette C Mueller; R Lupu
Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines.
International journal of oncology 2000;17(4):629-41.
2000: Angus M Tester; Neeracha Ruangpanit; R L Anderson; Erik W Thompson
MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits.
Clinical & experimental metastasis 2000;18(7):553-60.
1999: John T Price; T Tiganis; A Agarwal; D Djakiew; Erik W Thompson
Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase C-dependent mechanism.
Cancer research 1999;59(21):5475-8.
1999: Julie A Sharp; V Sung; J Slavin; Erik W Thompson; Michael A Henderson
Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
Laboratory investigation; a journal of technical methods and pathology 1999;79(7):869-77.
1999: Erik W Thompson; V Sung; M Lavigne; K Baumann; Norio Azumi; AD Aaron; Robert Clarke
LCC15-MB: a vimentin-positive human breast cancer cell line from a femoral bone metastasis.
Clinical & experimental metastasis 1999;17(3):193-204.
1999: Fudi Wang; K Nohara; Ana Olivera; Erik W Thompson; Sarah Spiegel
Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate.
Experimental cell research 1999;247(1):17-28.
1999: John T Price; Erik W Thompson
Models for studying cellular invasion of basement membranes.
Methods in molecular biology (Clifton, N.J.) 1999;129():231-49.
1998: Christine Gilles; J A Bassuk; Helena Pulyaeva; E H Sage; J M Foidart; Erik W Thompson
SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
Cancer research 1998;58(23):5529-36.
1998: V Sung; J T Stubbs; L Fisher; AD Aaron; Erik W Thompson
Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
Journal of cellular physiology 1998;176(3):482-94.
1998: Christelle Benaud; Robert B Dickson; Erik W Thompson
Roles of the matrix metalloproteinases in mammary gland development and cancer.
Breast cancer research and treatment 1998;50(2):97-116.
1998: V Sung; Christine Gilles; A Murray; Robert Clarke; AD Aaron; Norio Azumi; Erik W Thompson
The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype.
Experimental cell research 1998;241(2):273-84.
1998: Peter J Coopman; Michael Tri Do; Erik W Thompson; Susette C Mueller
Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(2):507-15.
1998: Muchieh Yu; H Sato; Motoharu Seiki; Sarah Spiegel; Erik W Thompson
Elevated cyclic AMP suppresses ConA-induced MT1-MMP expression in MDA-MB-231 human breast cancer cells.
Clinical & experimental metastasis 1998;16(2):185-91.
1997: Muchieh Yu; Emma T Bowden; J Sitlani; H Sato; Motoharu Seiki; Susette C Mueller; Erik W Thompson
Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells.
Cancer research 1997;57(22):5028-32.
1997: Christine Gilles; Myriam Polette; P Birembaut; Nils Brünner; Erik W Thompson
Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines.
Clinical & experimental metastasis 1997;15(5):519-26.
1997: Muchieh Yu; H Sato; Motoharu Seiki; Sarah Spiegel; Erik W Thompson
Calcium influx inhibits MT1-MMP processing and blocks MMP-2 activation.
FEBS letters 1997;412(3):568-72.
1997: H Nakahara; Linda Howard; Erik W Thompson; H Sato; Motoharu Seiki; Yunyun Yeh; Wen-Tien Chen
Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(15):7959-64.
1997: Christine Gilles; Myriam Polette; Motoharu Seiki; P Birembaut; Erik W Thompson
Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Laboratory investigation; a journal of technical methods and pathology 1997;76(5):651-60.
1997: V Sung; D A Cattell; J M Bueno; A Murray; JA Zwiebel; AD Aaron; Erik W Thompson
Human breast cancer cell metastasis to long bone and soft organs of nude mice: a quantitative assay.
Clinical & experimental metastasis 1997;15(2):173-83.
1997: Helena Pulyaeva; J Bueno; Myriam Polette; P Birembaut; H Sato; Motoharu Seiki; Erik W Thompson
MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells.
Clinical & experimental metastasis 1997;15(2):111-20.
1996: Christine Gilles; Myriam Polette; Jacques Piette; A C Delvigne; Erik W Thompson; Jean-Michel Foidart; Philippe Birembaut
Vimentin expression in cervical carcinomas: association with invasive and migratory potential.
The Journal of pathology 1996;180(2):175-80.
1996: B E Jones; Erik W Thompson; W Hodos; R J Waldbillig; Gerald J Chader
Scleral matrix metalloproteinases, serine proteinase activity and hydrational capacity are increased in myopia induced by retinal image degradation.
Experimental eye research 1996;63(4):369-81.
1996: Christine Gilles; Myriam Polette; Jacques Piette; Carine Munaut; Erik W Thompson; Philippe Birembaut; Jean-Michel Foidart
High level of MT-MMP expression is associated with invasiveness of cervical cancer cells.
International journal of cancer. Journal international du cancer 1996;65(2):209-13.
1995: D Giunciuglio; Martine Culty; Gianfranco Fassina; L Masiello; A Melchiori; G Paglialunga; G Arand; F Ciardiello; F Basolo; Erik W Thompson
Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes.
International journal of cancer. Journal international du cancer 1995;63(6):815-22.
1995: Muchieh Yu; H Sato; Motoharu Seiki; Erik W Thompson
Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells.
Cancer research 1995;55(15):3272-7.
1994: S N Maiti; Muchieh Yu; J Bueno; R H Tirgari; F L Palao-Marco; Helena Pulyaeva; Erik W Thompson
Differential regulation of matrix metalloproteinase-2 activation in human breast cancer cell lines.
Annals of the New York Academy of Sciences 1994;732():456-8.
1994: B E Jones; P Moshyedi; S Gallo; J Tombran-Tink; G Arand; D A Reid; Erik W Thompson; Gerald J Chader; R J Waldbillig
Characterization and novel activation of 72-kDa metalloproteinase in retinal interphotoreceptor matrix and Y-79 cell culture medium.
Experimental eye research 1994;59(3):257-69.
1994: Martine Culty; M Shizari; Erik W Thompson; C B Underhill
Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential.
Journal of cellular physiology 1994;160(2):275-86.
1994: Erik W Thompson; JA Torri; M Sabol; C L Sommers; Stephen W Byers; E M Valverius; G R Martin; Marc Lippman; M R Stampfer; Robert B Dickson
Oncogene-induced basement membrane invasiveness in human mammary epithelial cells.
Clinical & experimental metastasis 1994;12(3):181-94.
1994: Erik W Thompson; Muchieh Yu; J Bueno; L Jin; S N Maiti; F L Palao-Marco; Helena Pulyaeva; J W Tamborlane; R Tirgari; I Wapnir
Collagen induced MMP-2 activation in human breast cancer.
Breast cancer research and treatment 1994;31(2-3):357-70.
1994: Sarah Spiegel; Ana Olivera; H Zhang; Erik W Thompson; Y Su; A Berger
Sphingosine-1-phosphate, a novel second messenger involved in cell growth regulation and signal transduction, affects growth and invasiveness of human breast cancer cells.
Breast cancer research and treatment 1994;31(2-3):337-48.
1994: C L Sommers; Stephen W Byers; Erik W Thompson; JA Torri; Edward P Gelmann
Differentiation state and invasiveness of human breast cancer cell lines.
Breast cancer research and treatment 1994;31(2-3):325-35.
1994: Robert Clarke; Todd C Skaar; K Baumann; F Leonessa; M James; J Lippman; Erik W Thompson; CE Freter; N Brunner
Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression.
Breast cancer research and treatment 1994;31(2-3):237-48.
1994: A Staebler; C Sommers; Susette C Mueller; Stephen W Byers; Erik W Thompson; R Lupu
Modulation of breast cancer progression and differentiation by the gp30/heregulin [correction of neregulin].
Breast cancer research and treatment 1994;31(2-3):175-82.
1993: Hala S Azzam; G Arand; Marc Lippman; Erik W Thompson
Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.
Journal of the National Cancer Institute 1993;85(21):1758-64.
1993: Nils Brünner; T L Frandsen; C Holst-Hansen; M Bei; Erik W Thompson; A E Wakeling; Marc Lippman; Robert Clarke
MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.
Cancer research 1993;53(14):3229-32.
1993: Yuenian Shi; JA Torri; L Yieh; M E Sobel; Y Yamada; Marc Lippman; Robert B Dickson; Erik W Thompson
Expression of 67 kDa laminin receptor in human breast cancer cells: regulation by progestins.
Clinical & experimental metastasis 1993;11(3):251-61.
1993: Daniel Djakiew; BR Pflug; R Delsite; Makoto Onoda; John H Lynch; G Arand; Erik W Thompson
Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein.
Cancer research 1993;53(6):1416-20.
1993: S N Bae; G Arand; Hala S Azzam; P Pavasant; JA Torri; T L Frandsen; Erik W Thompson
Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays.
Breast cancer research and treatment 1993;24(3):241-55.
1993: Robert Clarke; Erik W Thompson; F Leonessa; J Lippman; M McGarvey; T L Frandsen; Nils Brünner
Hormone resistance, invasiveness, and metastatic potential in breast cancer.
Breast cancer research and treatment 1993;24(3):227-39.
1993: Erik W Thompson; Nils Brünner; JA Torri; Michael Johnson; V Boulay; A Wright; Marc Lippman; P S Steeg; Robert Clarke
The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells.
Clinical & experimental metastasis 1993;11(1):15-26.
1992: C L Sommers; S E Heckford; J M Skerker; P Worland; JA Torri; Erik W Thompson; Stephen W Byers; Edward P Gelmann
Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines.
Cancer research 1992;52(19):5190-7.
1992: Hala S Azzam; Erik W Thompson
Collagen-induced activation of the M(r) 72,000 type IV collagenase in normal and malignant human fibroblastoid cells.
Cancer research 1992;52(16):4540-4.
1992: Erik W Thompson; Soonmyung Paik; Nils Brünner; C L Sommers; Gerhard Zugmaier; Robert Clarke; T B Shima; JA Torri; S Donahue; Marc Lippman
Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
Journal of cellular physiology 1992;150(3):534-44.
1992: Edward P Gelmann; Erik W Thompson; C L Sommers
Invasive and metastatic properties of MCF-7 cells and rasH-transfected MCF-7 cell lines.
International journal of cancer. Journal international du cancer 1992;50(4):665-9.
1992: F Leonessa; V Boulay; A Wright; Erik W Thompson; Nils Brünner; Robert Clarke
The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs.
Acta oncologica (Stockholm, Sweden) 1992;31(2):115-23.
1991: Erik W Thompson; Marc Lippman; Robert B Dickson
Regulation of basement membrane invasiveness in human breast cancer model systems.
Molecular and cellular endocrinology 1991;82(1):C203-8.
1991: Q X Sang; Erik W Thompson; D Grant; William Stetler-Stevenson; Stephen W Byers
Soluble laminin and arginine-glycine-aspartic acid containing peptides differentially regulate type IV collagenase messenger RNA, activation, and localization in testicular cell culture.
Biology of reproduction 1991;45(3):387-94.
1991: C L Sommers; Erik W Thompson; JA Torri; R Kemler; Edward P Gelmann; Stephen W Byers
Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1991;2(8):365-72.
1991: Erik W Thompson; S Nakamura; T B Shima; A Melchiori; G R Martin; S Z Salahuddin; Robert C Gallo; Adriana Albini
Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness.
Cancer research 1991;51(10):2670-6.
1989: Erik W Thompson; D Katz; T B Shima; A E Wakeling; Marc Lippman; Robert B Dickson
ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness.
Cancer research 1989;49(24 Pt 1):6929-34.
1989: Robert Clarke; Nils Brünner; Benita S Katzenellenbogen; Erik W Thompson; M J Norman; C Koppi; Soonmyung Paik; Marc Lippman; Robert B Dickson
Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(10):3649-53.
1988: Erik W Thompson; Reuven Reich; T B Shima; Adriana Albini; J Graf; G R Martin; Robert B Dickson; Marc Lippman
Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens.
Cancer research 1988;48(23):6764-8.
1988: Reuven Reich; Erik W Thompson; Y Iwamoto; G R Martin; J R Deason; G C Fuller; Ruth Miskin
Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells.
Cancer research 1988;48(12):3307-12.